Clinical Trials for Checkpoint Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Checkpoint Therapeutics

Clinical Trials (1)

NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
PHASE1Active, not recruiting
272 participants
Started: Sep 20, 2017 · Completed: Dec 31, 2025
13 conditions2 sponsors48 locations